TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks July 30, 1982
TCL Archive Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue). May 9, 2003
TCL Archive In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director March 6, 1992
